2Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian protoncoupled metal-ion transporter. Nature 1997, 388 (6641) :482 - 488.
3Schmidt N, Ferger B. Neurochemical findings in the MPTP model of Parkinson' s disease. J Neural Transm 2001 , 108 : 1263 - 1282.
4Russ H, Staust K, Martel F, Gliese M, Schomig E. The extraneuronal transporter for monoamine transmitters existsin cells derived from human central nervous system gila.Eur J Neurosci 1996,8:1256 - 1264.
5Blum D, Torch S, Lambeng N, Nissou MF, Benabid AL,Sadoul R, Vema JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP:contribution to the apoptotic theory in Parkinson' s disease. Ping Neurobiol 2001 ,65 : 135 - 172.
6Mochizuki H, lmal H, Endo K, Yokomizo K, Murata Y,Hattorl N, Mizuno Y. Iron accumulation in the substantia nigra of 1-methy-4-phenyl-1, 2, 3, 6-tetrahydropyridine( MPTP)-induced hemiparkinsonian monkeys. Neurosci Iett 1994,68:251 -253.
7Yantiri FI Andersen JK. The role of iron in Parkinson'sdisease and 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. IUBMB Life 1999,8:139-141.
8He Y, Lee T, Leong SK.Time-course and localization of transgerring receptor expression in the substantia nigra of 6-hydroxydopamine-induced Parkinsonian rats. Neuroscience 1999 ,91 (2) :579 -585.
9hang L, lee T, Wang Y, Soong TW. Heterologous expression, functional characterization and localization of two isoforms of the monkey iron transporter Nramp2. J Biochem 2000,349:289 -297.
10Rouauh TA. Iron on the brain. Nature Genetics 2001 ,28(4): 299-300.
